In hematological malignancies p16INK4a and p15INK4b are frequently deleted e.g. in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) (66–70). The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.